Johnson & Johnson baby powder

A Johnson & Johnson subsidiary came under attack in court on February 14 for attempting to use the bankruptcy process to resolve tens of thousands of claims that J&J’s baby powder and other talc-based products caused cancer.

U.S. President Joe Biden on February 10 said mask requirements for children would likely to start to fall away given federal plans to begin vaccinating children under the age of 5, but said it was probably premature to drop COVID mask requirements entirely.

Global COVID-19 cases surpassed 400 million on February 9, according to a Reuters tally, as the highly contagious Omicron variant dominates the outbreak, pushing health systems in several countries to the brink of capacity.

Johnson & Johnson accused attorneys for people who have sued the pharmaceutical giant over the company’s talc products of sharing confidential documents with Reuters in what J&J called a “calculated effort” to try its subsidiary’s bankruptcy case in the press.

More than 100,000 Americans died from diabetes in 2021, marking the second consecutive year for that grim milestone and spurring a call for a federal mobilization similar to the fight against HIV/AIDS.

Merck & Co.’s new antiviral pill – once touted as a potential game changer for treating COVID-19 – is the last choice among four available options for at-risk patients given its relatively low efficacy and potential safety issues, U.S. doctors, healthcare systems and pharmacies told Reuters.

Omicron

The BA.2 subvariant of the Omicron coronavirus variant, which has quickly taken over in Denmark, is more transmissible than the more common BA.1 and more able to infect vaccinated people, a Danish study found.

Daily COVID-19 infections among athletes and team officials at the Beijing Winter Olympics jumped to 19 on Jan. 28 from two a day earlier, as Games organizers warned of more cases in coming days.

COVID tests

The United States government procured more than 100 million additional COVID-19 tests from testmaker iHealth Lab Inc. as part of the White House’s plan to distribute 500 million free at-home tests across the country, the Department of Defense said Jan. 28.

After a U.S. District Court judge ruled that the U.S. Food and Drug Administration must begin disclosing data surrounding the approval of COVID-19 vaccines within a span of eight months, Pfizer hopes to step in to ensure that no trade secrets are disclosed when the regulatory agency begins to share that information.